Par Drugs & Chemicals Ltd

Par Drugs & Che. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Par Drugs & Chemicals Ltd

₹ 87.3 -5.78%
15 May - close price
pardrugs.com NSE: PAR
About

Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals[1]

Key Points

Business Overview:[1]
PACL manufactures Active Pharma Ingredients for domestic and exports markets, they have a portfolio of 15 APIs and 10 Fine Chemicals. It produces the entire range of products in the Antacid Molecules segment

Website NSE
  • Market Cap ₹ 107 Cr.
  • Current Price ₹ 87.3
  • High / Low ₹ 122 / 78.0
  • Stock P/E 8.19
  • Book Value ₹ 91.0
  • Dividend Yield 0.00 %
  • ROCE 16.5 %
  • ROE 12.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.96 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 11.3% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
24.49 22.93 25.89 24.00 22.82 22.61 34.66 21.38 22.33 26.05 28.66 29.34 19.61
19.10 18.79 18.53 18.77 16.72 18.37 23.25 19.95 19.90 22.49 22.60 23.29 18.17
Operating Profit 5.39 4.14 7.36 5.23 6.10 4.24 11.41 1.43 2.43 3.56 6.06 6.05 1.44
OPM % 22.01% 18.05% 28.43% 21.79% 26.73% 18.75% 32.92% 6.69% 10.88% 13.67% 21.14% 20.62% 7.34%
0.03 0.01 0.05 0.23 -0.05 0.07 1.02 0.27 0.79 1.84 0.48 1.33 0.36
Interest 0.03 0.02 0.03 0.02 0.05 0.02 0.03 0.01 0.02 0.02 0.05 0.01 0.04
Depreciation 0.85 0.83 0.85 0.87 0.89 0.90 0.91 0.91 0.92 0.90 0.94 0.93 0.93
Profit before tax 4.54 3.30 6.53 4.57 5.11 3.39 11.49 0.78 2.28 4.48 5.55 6.44 0.83
Tax % 24.01% 25.15% 25.27% 25.16% 27.20% 25.07% 25.15% 24.36% 27.63% 25.67% 25.59% 25.47% -3.61%
3.45 2.47 4.89 3.42 3.72 2.53 8.60 0.58 1.65 3.33 4.13 4.80 0.85
EPS in Rs 2.80 2.01 3.97 2.78 3.02 2.06 6.99 0.47 1.34 2.71 3.36 3.90 0.69
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
33 33 49 42 46 56 61 75 96 96 101 104
26 26 40 34 38 46 45 59 78 73 81 87
Operating Profit 7 7 8 8 8 9 16 16 18 23 20 17
OPM % 22% 22% 17% 19% 18% 17% 26% 22% 19% 24% 19% 17%
0 0 0 0 0 0 2 0 0 0 2 4
Interest 4 4 2 2 2 1 1 0 0 0 0 0
Depreciation 2 3 3 3 3 3 3 3 3 3 4 4
Profit before tax 1 1 3 3 3 6 15 13 15 20 18 17
Tax % 27% 58% 42% 42% 24% 21% 21% 27% 25% 26% 26% 24%
1 0 2 2 3 5 12 9 11 14 13 13
EPS in Rs 1.65 0.78 3.43 2.78 2.79 3.87 9.44 7.49 9.21 11.78 10.86 10.65
Dividend Payout % 0% 0% 0% 0% 0% 32% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 11%
3 Years: 3%
TTM: 3%
Compounded Profit Growth
10 Years: 41%
5 Years: 5%
3 Years: 5%
TTM: 4%
Stock Price CAGR
10 Years: %
5 Years: 7%
3 Years: -25%
1 Year: -17%
Return on Equity
10 Years: 15%
5 Years: 15%
3 Years: 15%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3 3 3 3 4 6 6 12 12 12 12 12
Reserves 9 9 11 12 25 34 46 48 59 73 87 100
38 36 31 29 12 6 8 0 0 0 0 0
9 10 12 10 11 13 16 19 18 16 20 17
Total Liabilities 59 58 56 54 51 60 76 79 89 102 119 129
45 43 42 39 36 34 30 34 38 41 39 36
CWIP 0 0 0 0 0 1 5 0 0 0 0 1
Investments 0 0 0 0 0 0 0 0 0 0 25 27
13 15 14 15 15 25 42 44 50 60 55 65
Total Assets 59 58 56 54 51 60 76 79 89 102 119 129

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
9 7 9 4 2 8 12 8 13 20 16
-0 -0 -2 -1 -0 -1 0 -3 -7 -6 -25
-9 -5 -8 -4 -2 1 2 -10 0 0 0
Net Cash Flow -1 1 -1 0 -0 7 14 -5 6 14 -9
Free Cash Flow 9 6 7 4 2 6 12 4 6 14 15
CFO/OP 127% 91% 116% 59% 34% 90% 98% 66% 97% 108% 106%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 83 81 61 75 67 81 75 90 65 52 60 42
Inventory Days 111 158 69 83 81 45 50 60 49 45 58 45
Days Payable 184 183 135 107 94 96 112 135 73 58 104 69
Cash Conversion Cycle 10 57 -5 51 55 30 13 14 40 40 15 19
Working Capital Days 61 66 -46 -26 13 39 24 61 50 40 39 31
ROCE % 10% 9% 12% 11% 12% 16% 25% 22% 23% 25% 18% 17%

Insights

In beta
Mar 2017 Mar 2018 Mar 2019 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Total Installed Capacity
MTPA

Log in to view insights

Please log in to see hidden values.

Login
Capacity Utilization
%
Total Permanent Employees
Count
Utilized Production / Sales Quantity
MTPA
Export Presence (Number of Countries)
Count
Solar Power Generation
kWh
Total Number of Products Manufactured
Count
Number of Customers
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.21% 74.21% 74.21% 74.21% 74.21% 73.37% 73.37% 73.37% 73.37% 73.37% 73.41% 73.41%
0.00% 0.00% 0.07% 0.07% 0.32% 0.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
25.79% 25.79% 25.73% 25.68% 25.47% 26.54% 26.63% 26.63% 26.63% 26.63% 26.59% 26.59%
No. of Shareholders 5,6865,9027,0207,4038,0228,75717,18915,47214,88714,28013,76113,222

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls

  • Jun 2023
    Transcript
    AI Summary
    PPT
  • Jun 2023
    Transcript
    AI Summary
    PPT
  • Mar 2023
    Transcript
    AI Summary
    PPT
  • Mar 2023
    Transcript
    AI Summary
    PPT
  • Feb 2023
    Transcript
    AI Summary
    PPT
  • Nov 2022
    Transcript
    AI Summary
    PPT
  • Nov 2022
    Transcript
    AI Summary
    PPT
  • Aug 2022
    Transcript
    AI Summary
    PPT
  • May 2022
    Transcript
    AI Summary
    PPT
  • Feb 2022
    Transcript
    AI Summary
    PPT
  • Dec 2021
    Transcript
    AI Summary
    PPT
  • Nov 2021
    Transcript
    AI Summary
    PPT
  • Jun 2021
    Transcript
    AI Summary
    PPT
  • Nov 2020
    Transcript
    AI Summary
    PPT
  • Nov 2020
    Transcript
    AI Summary
    PPT
  • Jun 2020
    Transcript
    AI Summary
    PPT
  • Sep 2019
    Transcript
    AI Summary
    PPT